Conditions: Pediculosis
Keywords: Head Lice
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
In a previous phase II study, the safety and efficacy of a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older. Based on the results of that study, this formulation is currently in a phase III study for that population.

The current study will use blood markers and clinical evaluations to determine the safety and tolerability of this formulation when used in children 6-24 months of age.

Detailed description:

Arms:
arm 1: MALG treatment

Interventions: intervention 1: MALG (malathion) Treatment
Intervention descriptions: intervention 1: MALG applied for 30 minutes

Protocol document: